The Institute generates news every day. Some findings are groundbreaking—some represent smaller steps. But ultimately, it is the combination of both that makes scientific advancement possible. Here is a little selection of the latest stories making it out to the wider world.
For about six months since March, around 50 postdocs, PhDs and master students at the LIT went through an entire curriculum program mediating knowledge about Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP).
A “Nature Communications” study from the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation” reveals how a microbial metabolite safeguards the intestinal barrier and drives stem cell-mediated regeneration after injury.
Peter Aumer, member of the German Bundestag, came to the LIT to visit the exhibition “Alzheimer’s Research Meets Art” providing insights into the world of biomedicine.
“Stay curious.” That is only one of the practical pieces of advice Roland Schelker gives in his interview for early-career researchers. The statements are published on Immunopaedia.org, a non-profit platform providing free immunology education. Schelker, Head of the Translation Group “T-Cell Fitness”, recently became an Associate Professor at the University of Regensburg.
In the latest episode of the podcast “Wirkstoffradio”, Bernd Rupp sits down with Dr. Dr. Roland Schelker, Head of Translation Group “T-Cell Fitness” at the Leibniz Institute for Immunotherapy, to dive deep into the fascinating world of immune cells – especially T cells.
The 2025 Taylor Prize is dedicated to the transformative potential of cell-based immunotherapy. As Western University, London, Ontario, Canada, in its award announcement says, Prof. Carl H. June’s work is “advancing our understanding of immune-based treatments and reshaping the possibilities of human health”. The Taylor Prize is one of Canada’s most prestigious medical research prizes and includes a cash award of 50,000 U.S. dollars.
In a recent article published in nature reviews immunology, LIT scientists, Dr. Jeremy G. Baldwin, Dr. Christoph Heuser-Loy, and Prof. Luca Gattinoni, provide an update on the latest advances in our understanding of how organelles govern T-cell function and how this knowledge can be leveraged to improve the therapeutic efficacy of cancer immunotherapies.
On Tuesday, October 7, Prof. Philipp Beckhove opened the exhibition of paintings by Prof. Stefan Rüdiger with a festive vernissage: Bright colors shine against a dark blue backdrop in the foyer of the main entrance at Regensburg University Hospital, encouraging visitors to learn about current Alzheimer’s research. The exhibition is open to the public until October 29, and admission is free of charge.
The Nobel Commitee awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for their groundbreaking discoveries related to peripheral immune tolerance.
In a recent article published in “Nature Reviews Gastroenterology & Hepatology”, LIT scientist Prof. Hinrich Abken comprehensively reviews the state-of-the art in chimeric antigen receptor (CAR) T cell therapy in gastrointestinal tumors and discusses challenges and emerging solutions to overcome treatment resistance of solid tumors. This overview is especially important for oncologists, immunologists, and medical researchers interested in cellular therapies against cancer.
